MetLife Inc. (MET)
MetLife Inc. (MET) is currently priced at $97.10, demonstrating robust performance within the Insurance - Life sector. The stock is trading above its 50-day and 200-day Simple Moving Averages, alongside its 20-day Exponential Moving Average, signaling positive price action. Revenue growth of 10.5% indicates healthy expansion, and the company offers a dividend yield of 2.39%, providing a component of return for investors.
While insiders are net sellers, with $3.8M in sales versus no reported purchases, the overall technical picture remains strong. The RSI is at 63.37, indicating bullish momentum without being overbought. The P/E ratio stands at 18.73, which is slightly above the sector average, but this is offset by its consistent revenue growth and dividend payout.
MET Price Analysis
Market Metrics
Peer Benchmarking
Valuation vs Sector (Financial Services)
Performance vs XLF
Sector Position Analysis
MET Analysis
MetLife Inc. (MET) exhibits a strong bullish technical profile. The stock is trading comfortably above its 50-day SMA ($90.44) and 200-day SMA ($80.34), with the 50-day SMA also above the 200-day SMA, indicating an established uptrend. The 20-day EMA ($95.36) is also below the current price, reinforcing short-term bullish sentiment.
The Relative Strength Index (RSI) at 63.37 suggests strong upward momentum without entering overbought territory. The MACD value of 2.13 further supports this positive trend. Key support levels can be inferred from the moving averages, with the 50-day SMA acting as a near-term floor. The Stochastic Oscillator at 60.01 indicates the market is not overextended, leaving room for further upside.
- Monitor insider transactions closely; a shift from net selling to net buying could signal increased confidence and provide a bullish catalyst.
- Given the bullish technicals, consider using moving averages like the 50-day SMA as potential support levels for entry or stop-loss points.
- The insurance sector can be sensitive to interest rate fluctuations. Stay informed about macroeconomic trends that could impact MetLife's investment portfolio and profitability.
MetLife Inc. reported a revenue growth of 10.5%, outperforming the sector average and indicating strong business expansion.
Source: Company DataThe stock is trading above key moving averages (50-day SMA, 200-day SMA, 20-day EMA) with a bullish RSI, suggesting sustained upward price action.
Source: Technical AnalysisInsiders have sold $3.8 million worth of stock with no reported purchases, indicating a moderate insider selling and potential lack of immediate insider conviction.
Source: Insider SummaryMetLife Inc. offers a dividend yield of 2.39%, providing a consistent income stream for shareholders.
Source: Company DataMetLife Inc. (MET) is poised for continued positive performance in the next 6-12 months, driven by its strong technical positioning and healthy revenue growth. The stock's ability to trade above key moving averages suggests that the current uptrend is likely to persist, potentially pushing prices towards new short-term highs. The dividend yield of 2.39% provides a stable return, making it attractive for income-focused investors.
Upside potential could be further enhanced if insider sentiment shifts to net buying or if the company reports earnings that significantly exceed expectations. Conversely, a sharp increase in interest rates or unexpected regulatory changes within the insurance sector could pose downside risks, potentially reversing the current bullish momentum and impacting profitability.
Key Statistics
| Market Cap | 61.66B |
| P/E Ratio | 18.73 |
| EPS (TTM) | 5.22 |
| Dividend Yield | 2.39% |
| 52 Week High | 100.93 |
| 52 Week Low | 67.33 |
MetLife Inc. (MET) presents a P/E ratio of 18.73, which is marginally higher than the estimated sector average of 15.5. This valuation is supported by a solid EPS of $5.22 and a revenue growth rate of 10.5%, which outpaces the sector average of 8.5%. The company's market capitalization stands at $61.66 billion, positioning it as a significant player in the insurance industry.
The dividend yield of 2.39% offers an attractive income stream for investors. While the P/E ratio suggests a slight premium, the robust revenue growth and consistent dividend payout provide a fundamental justification for this valuation. Further analysis of profit margins and balance sheet health would be beneficial for a complete picture.
Earnings & Growth Analysis
MetLife Inc. (MET) reported an Earnings Per Share (EPS) of $5.22. While specific recent earnings performance details (beat/miss) are not provided in the data, the positive EPS figure contributes to the company's valuation metrics. The reported revenue growth of 10.5% suggests a healthy top-line trajectory, which is a positive indicator for future earnings potential.
The company's ability to generate consistent earnings and revenue growth is crucial for its long-term financial health and its capacity to sustain dividend payments. Investors should monitor upcoming earnings reports for forward guidance and any shifts in profitability trends.
Key Risks
A primary risk for MetLife Inc. (MET) stems from insider selling, with $3.8 million in sales reported against no purchases, indicating a net seller position among insiders. Although the technicals are bullish, this insider activity warrants caution and suggests potential headwinds or a lack of immediate conviction from management.
The P/E ratio of 18.73 is slightly elevated compared to the sector average, presenting a valuation risk if growth expectations are not met. Additionally, the insurance industry is subject to regulatory changes and macroeconomic shifts that could impact profitability and solvency.
Technical Indicators
| RSI (14) | 63.37 |
| MACD | 2.13 |
| SMA 50 | 90.44 |
| SMA 200 | 80.34 |
Market Correlations
How this stock moves relative to other assets
Based on 1 year of daily price data. Correlations may vary over different time periods.
MET Trade Plans
Specific entry, exit, and risk management levels
🟢 LONG ENTRY (click to switch)
Risk Management
Profit Targets (Based on Conservative Entry)
Growth of $10,000
Compare with Another Ticker
Monte Carlo Projection (10yr)
People Also Watch
Compare MET
MET Insider Trading Analysis
Source: SEC Form 4| Date | Insider | Type | Shares | Value |
|---|